Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report

The paper describes a clinical case of a female patient with chronic migraine (CM) and shows a modern approach to diagnosing CM and assessing chronicity factors. The patient received interdisciplinary treatment that involved standard therapy and cognitive behavioral therapy (CBT), a psychological treatment for pain and emotional disorders. The use of CBT in this clinical case was justified by the fact that the patient had pain catastrophizing, emotional disorder, abuse of painkillers and their discontinuation problems, and unsatisfactory tolerability of preventive pharmacotherapy for migraine. CBT could change the patient's ideas about the causes and prognosis of the disease, increase her intraday activity, teach effective skills to overcome pain, and cope with the symptoms of anxiety and depression. A long-term (12-month) follow-up of the female patient receiving behavioral interdisciplinary treatment showed a clinically significant improvement as transformation from chronic to episodic of migraine, as normalization of the emotional state, and as an increase in daily activity.

chronic migraine, chronicity, diagnosis, treatment, cognitive behavioral therapy, psychological methods

1. Ayzenberg I, Katsarava Z, Sborowski A, et al. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured health care for headache is urgently needed. Eur J Neurol. 2014 May;21(5):758-65. doi: 10.1111/ene.12380. Epub 2014 Feb 13.

2. Baykan B, Ertas M, Karli N, et al. Migraine incidence in 5 years: a population-based prospective longitudinal study in Turkey. J Headache Pain. 2015;16:103. doi: 10.1186/s10194-015-0589-2. Epub 2015 Dec 3.

3. Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010 May;30(5):599-609. doi: 10.1111/j.1468-2982.2009.01941.x

4. Ayzenberg I, Katsarava Z, Sborowski A, et al. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012 Apr;32(5):373-81. doi: 10.1177/0333102412438977. Epub 2012 Mar 6.

5. Osipova V, Ayzenberg I, Amelin A, et al. The highest prevalence of CDH in Russia: why? Cephalalgia. 2015;35(6S):287. doi: 10.1177/0333102415581304.

6. Kavuk I, Yavuz A, Cetindere U, et al. Epidemiology of chronic daily headache. Eur J Med Res. 2003 Jun 30;8(6):236-40.

7. Golovacheva VA, Parfenov VA, Tabeyeva GR, et al. The optimization of management of chronic daily headache patients. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2017;117(2):4-9. doi: 10.17116/jnevro2017117214-9 (In Russ.).

8. Green MW, Muskin PR. The neuropsychiatry of headache. UK: Cambridge University Press; 2013. 169 p.

9. Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Russian experts' recommendations. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020; 12(4):4-14. doi: 10.14412/2074-2711-2020-4-4-14 (In Russ.).

10. Agostoni EC, Barbanti P, Calabresi P, et al; Italian chronic migraine group. Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain. 2019 Aug 30;20(1):92. doi: 10.1186/s10194-019-1038-4

11. Ha H, Gonzalez A. Migraine Headache Prophylaxis. Am Fam Physician. 2019 Jan 1;99(1):17-24. Available from: https://www.aafp.org/afp/2019/0101/p17.html

12. Tabeeva GR, Katsarava Z. Current concept of the pathophysiology of migraine and new targets for its therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):143-52. doi: 10.14412/2074-27112020-4-143-152 (In Russ.).

13. Schulman EA, Lake AE 3rd, Goadsby PJ, et al. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. Headache. 2008;48(6):778-82. doi: 10.1111/j.15264610.2008.01132.x

14. Lee HJ, Lee JH, Cho EY, et al. Efficacy of psychological treatment for headache disorder: a systematic review and meta-analysis. J Headache Pain. 2019 Feb 14;20(1):17. doi: 10.1186/s10194-019-0965-4

15. Sharpe L, Dudeney J, Williams ACDC, et al. Psychological therapies for the prevention of migraine in adults. Cochrane Database Syst Rev. 2019 Jul 2;7(7):CD012295. doi: 10.1002/14651858.CD012295.pub2

16. Maizels M. The patient with daily headaches. Am Fam Physician. 2004 Dec 15;70(12):2299-306. Available from: https://www.aafp.org/afp/2004/1215/p2299.html

17. Bashir A, Lipton RB, Ashina S, Ashina M. Migraine and structural changes in the brain: a systematic review and metaanalysis. Neurology. 2013 Oct 1;81(14):1260-8. doi: 10.1212/WNL.0b013e3182a6cb32. Epub 2013 Aug 28.

18. Golovacheva VA, Pozhidaev KA, Golovacheva AA. Cognitive impairment in patients with migraine: causes, principles of effective prevention and treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):141-9. doi: 10.14412/2074-27112018-3-141-149 (In Russ.).

19. The International Classification of Headache Disorders, 3 rd edition (ICHD-3). Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202

20. Evers S, Jensen R; European Federation of Neurological Societies. Treatment of medication overuse headache – guideline of the EFNS headache panel. Eur J Neurol. 2011 Sep;18(9):1115-21. doi: 10.1111/j.14681331.2011.03497.x

21. Beck AT. A 60-Year Evolution of Cognitive Theory and Therapy. Perspect Psychol Sci. 2019 Jan;14(1):16-20. doi: 10.1177/1745691618804187

22. Raggi A, Grignani E, Leonardi M, et al. Behavioral Approaches for Primary Headaches: Recent Advances. Headache. 2018 Jun;58(6):913-25. doi: 10.1111/head.13337. Epub 2018 May 26.

23. Anheyer D, Leach MJ, Klose P, et al. Mindfulness-based stress reduction for treating chronic headache: A systematic review and meta-analysis. Cephalalgia. 2019 Apr;39(4):544-55. doi: 10.1177/0333102418781795. Epub 2018 Jun 4.

24. Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008 Sep;48(8):1157-68. doi: 10.1111/j.15264610.2008.01217.x

25. Aurora SK, Brin MF. Chronic migraine: an update on physiology, imaging, and the mechanism of action of two available pharmacologic therapies. Headache. 2017 Jan;57(1):109-25. doi: 10.1111/head.12999. Epub 2016 Dec 2.

26. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003 Nov;106(1-2):81-9. doi: 10.1016/s0304-3959(03)00293-8

27. Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012 Feb;16(1):86-92. doi: 10.1007/s11916-011-0233-z

28. Osipova VV, Azimova YuE, Tabeeva GR, et al. Diagnosis of headaches in Russia and the countries of the former Soviet Union: the state of the problem and ways to solve it. Annaly klinicheskoy i eksperimental'noy nevrologii. 2012;6(2):16-21. Available from: https://cyberleninka.ru/article/n/diagnostika-golovnyhboley-v-rossii-i-stranah-postsovetskogo-prostranstva-sostoyanie-problemy-i-puti-ee-resheniya/viewer (In Russ.).

29. Lebedeva ER, Kobzeva NR, Gilev DV, Olesen E. Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural Region. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2015;7(1):1926. doi: 10.14412/2074-2711-2015-1-19-26 (In Russ.).

30. Rabe K, Pageler L, Gaul C, et al. Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2013 Feb;33(3):202-7. doi: 10.1177/0333102412462638. Epub 2012 Oct 23.

31. Osipova VV, Filatova EG, Artemenko AR, et al. Diagnosis and treatment of migraine: recommendations of Russian experts. Zhurnal nevrologii i psikhiatrii im. Korsakova. 2017;(2):28-42. doi: 10.17116/jnevro20171171228-42 (In Russ.).